ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,013Medicare Part D Prescriptions Filled, Including Refills

Rank: 378 out of 2061

$726K Total Retail Price of All Prescriptions

Rank: 322 out of 2061

174 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

25% of this provider’s 174 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 174 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 6,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
OMEPRAZOLE 345 187 1 5
FUROSEMIDE 330 265 2 6
DIVALPROEX SODIUM 281 135 3 74
LEVOTHYROXINE SODIUM 272 192 4 3
LISINOPRIL 259 190 5 2
SIMVASTATIN 234 183 6 1
RISPERIDONE 207 116 7 66
AMLODIPINE BESYLATE 203 140 8 4
WARFARIN SODIUM 201 145 9 11
OXYCODONE HCL 197 23 S2 10 82
LANTUS 193 104 11 48
POTASSIUM CHLORIDE 187 130 12 16
OXYCODONE-ACETAMINOPHEN 185 142 S2 13 36
METOPROLOL TARTRATE 184 75 14 7
CITALOPRAM HBR 169 70 15 20
HYDROCHLOROTHIAZIDE 168 94 16 12
GABAPENTIN 151 86 17 15
DONEPEZIL HCL 126 80 18 24
NOVOLOG 124 71 19 102
SERTRALINE HCL 122 50 20 21
CYMBALTA 113 46 21 59
SILVER SULFADIAZINE 110 64 22 321
TAMSULOSIN HCL 109 76 23 30
METFORMIN HCL 109 70 23 9
LANTUS SOLOSTAR 102 67 25 76
SPIRIVA 101 69 26 63
FLUPHENAZINE HCL 100 51 27 327
QUETIAPINE FUMARATE 99 49 28 72
JANTOVEN 98 60 29 93
CARBIDOPA-LEVODOPA 98 74 29 97
OLANZAPINE 94 44 31 132
CIPROFLOXACIN HCL 89 74 32 54
CARVEDILOL 89 80 32 22
PROMETHAZINE HCL 88 43 R 34 119
HYDROCODONE-ACETAMINOPHEN 86 32 S3 35 10
MELOXICAM 82 26 36 44
NAMENDA 80 56 37 37
FAMOTIDINE 80 29 37 67
ATORVASTATIN CALCIUM 79 50 39 8
ZOLPIDEM TARTRATE 79 20 39 23
LEVETIRACETAM 71 45 41 102
ALENDRONATE SODIUM 70 37 42 25
LIDODERM 69 58 43 106
METOPROLOL SUCCINATE 64 57 44 19
OXYCONTIN 64 44 S2 44 154
CARBAMAZEPINE 62 38 46 187
KLOR-CON M20 60 38 47 47
NITROFURANTOIN MONO-MACRO 60 48 47 162
MIRTAZAPINE 59 56 49 46
LOSARTAN POTASSIUM 56 33 50 17
NOVOLIN R 56 30 50 129
NYSTATIN 54 0 52 148
PERPHENAZINE 52 0 53 381
FENOFIBRATE 52 28 53 65
AMOX TR-POTASSIUM CLAVULANATE 52 30 53 113
TRAZODONE HCL 52 35 53 39
ATENOLOL 51 38 57 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.